Clinical Trials Logo

Clinical Trial Summary

The natural history of subfoveal CNV secondary to Pattern Dystrophy is little understood, but it seems that visual function may be preserved only in the short-term follow-up, with progressive deterioration thereafter.

Photodynamic therapy with verteporfin is the most studied therapeuthic option for this kindf of lesion, but unfortunately, this approach does not appear to guarantee long-term vision stabilization, and alternative therapies should be investigated.


Clinical Trial Description

Diagnosis of Pattern Dystrophy Diagnosis of subfoveal CNV Intravitreal injection of avastin (1.25 mg) in operating room under sterile condition.

Retreatment on the basis of the detection of disease progression and of lack of central retinal thickness reduction on OCT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00391144
Study type Interventional
Source University of Trieste
Contact Maurizio B Parodi, MD
Phone +39 040 772449
Email maubp@yahoo.it
Status Unknown status
Phase Phase 2/Phase 3
Start date July 2006
Completion date October 2006